Evaluation of accuracy and safety of the next-generation up to 180-day long-term implantable eversense continuous glucose monitoring system: the PROMISE study
Garg SK, Liljenquist D, Bode B, et al.
Diabetes Technol Ther. 2022;24(2):84-92.
Leggi
Garg SK, Liljenquist D, Bode B, et al.
Diabetes Technol Ther. 2022;24(2):84-92.
Leggi
Kanapka LG, Lum JW, Beck RW
Diabetes Technol Ther. Pub. online 23 February 2022.
Leggi
Hammerman A, Moore CM, Aboalhasan E, et al.
Am J Cardiol. 2022;S0002-9149(22)00093-5.
Leggi
Lam CSP, Ramasundarahettige C, Branch KRH, et al.
Circulation. 2022;145(8):565-574.
Leggi
Stefan N, Cusi K
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00003-1.
Leggi
Patarrão RS, Duarte N, Penha-Gonçalves C, et al.
Diabetologia. Pub. online 22 February 2022.
Leggi
24/02/2022
Leggi
Algeffari M, Hussain S, Almogbel T, et al.
Diabetes Care. 2022;dc211655.
Leggi
Yan X, Song JF, Zhang L, Li X
BMC Endocr Disord. 2022;22(1):46.
Leggi
Shaman AM, Bain SC, Bakris GL, et al.
Circulation. 2022;145(8):575-585.
Leggi